At Debiopharm, every step we take is guided by one purpose: improving the lives of people affected by cancer and infectious diseases. As a privately‑owned Swiss biopharmaceutical company, we’re driven by science, but above all, by the people behind every treatment — the patients and their families.

Through our unique “development only” model, we bring forward promising therapies and transform them into treatments that can reach those who need them most, faster.

Are you ready to bridge the gap between breakthrough science and commercial success?

We are currently looking for a dynamic Global Early Commercial Manager to shape the future of our oncology portfolio. In this pivotal role, you will be the commercial voice within Core Project Teams, driving the strategy for assets from preclinical stages through the start of Phase 3. Your mission is to maximize asset value and ensure our innovations meet the real‑world needs of patients and provider...